LogoTestata.png

logo instagram 35x35.png  logo youtube 35x35.png logo twitter 35x35.png logo facebook 35x35.png

Mazzanti Cinzia

Chi sono

Attività Scientifica

1.    G Richard, AR Wright, S Harris, SZ Doyle, B Korgee, C Mazzanti, T Tanaka et aI. Fine mapping of the Darier's disease locus on chromosome 12q. J Invest Dermatol 1994; 103: 665-8. IP:4.822

2.    T.Gobello, C.Mazzanti, P.Fileccia, B.Didona M.Papi, F.Atzori, R.Cavalieri. X-linked dominant chondrodysplasia punctata (Happle syndrome) with uncommon symmetrical shortening of the tubular bones. Dermatology 1995; 191: 323-327. IP: 0.685

3.    A.M. Christiano, A.Morricone, M.Paradisi, C.Angelo, C.Mazzanti, R.Cavalieri, J.Uitto. A glycine-to-arginine substitution in  the  tripiehelical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa. J. Invest. Dermatol. 1995;104: 438-440. IP:4.822

4.    G.Richard, B.P.Korge, A.R. Wright, C.Mazzanti, W.Harth, M. Annicchiarico-Petruzzelli, J. G. Compton, S.J. Bale. Hailey Hailey disease maps to a 5 cM interval' on chromosome 3q21-q24. J. Invest. Dermatol. 1995;105: 357-360. IP:4.822

5.    AM Christiano, M DAlessio, M Paradisi, C Angelo, C Mazzanti, P Puddu, J Uitto. A common insertion mutation in COL7A in two Italian families with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1996; 106: 679 84. IP:4.822

6.    M.Pa pi, B. Didona, L.M. Chinni et al. Koebner phenomenon in an ANCA - Positive patient with pyoderma gangrenosum. J Dermatol 1997; 24:583 6.

7.    C. Mazzanti, T.Gobello, P.Posteraro et al. 180-kDa bullous pemphigoid antigen defectivecgeneralized atrophic benign epidermolysis bullosa: report of four cases with an unusually mild phenotype. British Journal of Dermatology 1998,_ 138: 859-866. IP: 2.017

8.    V.L.Ruiz-Perez, S.A.Carter, E. Healy, C. Mazzanti et aI. ATP2A2 mutations in Darier's disease: variant cutaneous phenotypes are assoc!ated with missense mutations, but neuropsychiatric features are independent of mutation class.Human Molecular Genetics, 1999;8,1621 1630. IP: 9.307

9.    F. Capon, G. Novell! S. Semprini, C. Mazzanti et aI. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol 1999; 112:32-5. IP:4.822

10.    AQ Terrinoni, E Candi, S Oddi, C Mazzanti et al. A glutamine insertion in the IA alpha helical domain of the keratin 4 gene in a familial case of white sponge nevus. J Invest Dermatoi 2000; 114: 388-91. IP:4.822

11.     AQ Terrinoni, E Candi, S Oddi, C Mazzanti et al. A glutamine insertion in the IA alpha helical domain of the keratin 4 gene in a familial case of white sponge nevus. J Invest Dermatoi 2000; 114: 388-91. IP:4.822

12.    L. Ruzzi H Pas, P Posteraro, C Mazzanti, B Didona, K Owaribe, G Meneguzzi, G Zambruno, D Castiglia, M DAlessio. A Homozygous nonsense mutation in type XVII collagen gene (COL17A1) uncovers an alternatively spliced mRNA accounting for an unusually mild form of non-Herlitz junctional epidermolysis bullosa. J Invest Dermatol 2001; 116:1-6   IP:4.822.

13.    F Ringfeil, A Raus, J J Di Giovanna, 8 Korge, W Hart, C Mazzanti, J Uitto, S J Bale, G Richard. Darier disease- novel mutations in ATP2A2 and genotype-phenotype correlation. Exp Der matol 2001: 10: 19-27.

14.    R Corona, E Dogliotti, M DErrico, F Sera, T Lavarone, G Baliva, L M Chinni, T Gobello, C Mazzanti, P Puddu, P Pasquini. Risk  factors for basal cell carcinoma in a mediterranean population. Arch Dermatol 2001:137: 1162~ 1168.

15.    T Gobello, C Mazzanti, D. Sordi, G Annessi, D Abeni, L M Chinni, G Girolomoni~ Medium- versus High-dose ultraviolet Al therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol 2003; 49: 679-84.

16.    M Scaturro, P Posteraro, A Mastrogiacomo, M L Zaccaria, N De Luca, C Mazzanti, G Zambruno, D Castiglia.  A Missense mutation (G1506E) in the adhesion G domain of laminin-5 causes mild junctional epidermolysis bullosa. Biochemical and biophysical research communications 309 (2003), 96-103.

17.    P. Amerio, T. Gobello, C. Mazzanti, E. Giaculli, S. Ruggeri et aI. Photodynamic therapy plus topical retinoids in Darier's disease. Photodiagnosis and Photodynamic therapy. 2007:4, 36-38.

18.    Effect of written emotional disclosure interventions in persons with psoriasis undergoing narrow band ultraviolet 8 phototherapy. Paradisi A, Abeni D, Finore E, Di Pietro C, Sampogna F, Mazzanti C, Pilfa MA, Tabolli S. Eur J Dermatol. 2010 Sep-Oct;20(5):599-605. Epub 2010 Jul 7.

19.    No evidence for fetal microchimerism in the skin of patients with pemphigoid gestationis. D'Alessio MC, Mazzanti C, Di Simone N, Mancuso S, Reddiconto G, Garzia M, Leone G, Gobello T, Caruso A. Eur J Dermatol. 2010 Jan - Feb;20(1):122-3. Epub 2009 Oct 20.

20.    Psychological status of patients with alopecia areata.  Alfani S, Ant|none V, Mozzetta A, Di Pietro C, Mazzanti C, Stella P, Raskovich D, Abeni D. Acta perm Venereol. 2012 May;92(3):304-6. doi: 10.2340/00015555-1239

21.    Full sequencing of the FLG gene in Italian patients with atopic eczema: evidence of new mutations, but lack of an association.   Cascella R, Foti Cuzzola V Lepre T, Gall| E, Moschese V, Chini L, Mazzanti C Fortugno P, Novelli G, Giardina E. J Invest Dermatol. 2011 Apr;131(4):982-4.

22.    Psychological status of patients with alopecia areata. Alfani S, Antinone V, Di Pietro C, Mazzanti C. et aI. Acta Derm Venereol. 2012 May; 92 (3): 304-306.

23.    Ichthiosis linearis circumflexa as the only clinical manifestation of Nethrton Syndroma. Guerra L., Fortugno P, Pedicellf C, Mazzanti C et al. Acta Derm Venereol. 2015 Feb 24. doi: 10.2340/00015555-2075

24.    Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th) I and Thl7 cells in alopecia areata patients. Avitabile $1, Sordi D, Garcovich S, Colonna L, De Luca A, Nasorri F, Mazzanti C, Cavani A. J Dermatol. 2015 Jan;42(1):98-9.

25.    Pemphigoid Gestationis Complicating an Egg Donation Pregnancy. Guerra L, Mazzanti C, Calabresi V, De Luca N, Zambruno G, Di Zenzo G. Acta Derm Venereol. 2016 Jun 15;96(5):695-6. doi: 10.2340/00015555-2303

26.    Characterization of TG2 and TGI-TG2 double knock-out mouse epidermis. Pitolli C, Pietroni V, Marekov L, Terrinoni A, Yamanishi K, Mazzanti C, Melino G, Candi E. Aminoacids 001 10.107 2016 Nov 18.

27.    Tattoo and warts: new concepts and topical immunotherapy. L. Fania, D. Sordf, G. Pagnanelli, A. Cavani, C. Mazzanti. Eur J Dermatol. 2017 Jun 1;27(3):322-323.

28.    Prevalence  and incidence  of  hidradenitfs  suppurativa:  an  exercise  on indirect estimation from psoriasis data. L. Fania, F. Ricci, F Sampogna, C. Mazzanti, B. Didona, G. Pintori, D. Abeni. J Eur Acad Dermatol Venereof. 2017 Sep;31(9):e410-e411.

29.    Scleredema of Buschke with prominent periorbital edema. L. Fania, L. Colonna, G. Pagnanelli, D Abeni, G. Annessi, C. Mazzanti. Int J Dermatol. 2017 Oct;56(10):e193-e194.

30.     Simvastatin-associated dermatomyositis. L. Fania, D. Didona, T. Tonanzi, C. Mazzanti, B. Didona. Dermatol Ther. 2017 Jul;30(4). doi: 10.1111/dth.12480.

31.    Detection and characterization of lgG, lgE and lgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase- IV Inhibitors. Fania L, Salemme A, Prov'mi A, Pagnanelli G, Colfina MC, Abeni D, Didona B, Di Zenzo G, Mazzanti C. J Am Acad Dermatol. 2017 Oct 4.

32.    Increased prevalence of diabetes mellitus in bullous pemphigoid patients during the last decade. Fania L, Di Zenzo G, Didona B, PiIla MA, Sobrino L, Panebianco A, Mazzanti C Abeni D~ J Eur Acad Dermatol Venereol. 2017 Oct 21.

33.    Commentary on "Changing prevalence of diabetes mellitus in bullous pemphigoid: It is the dipeptidyl peptidase-4 inhibitors". Fania L, Di Zenzo G, Mazzanti C,  Abeni D. J Eur Acad Dermatol Venereol. 2018 Mar 23.